Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
KIRC | rs6587679 | chr1:152481262 | G/A | 3.56E-5 | 508 | 33.87 | 44.77 | 37.77 | KM Plot |
KIRC | rs66462826 | chr6:50814877 | C/A | 5.17E-6 | 519 | 40.5 | 40.3 | 15.3 | KM Plot |
KIRC | rs666160 | chr11:125326615 | A/G | 3.08E-6 | 516 | 40.8 | 37.03 | 1.43 | KM Plot |
KIRC | rs66675690 | chr7:46582660 | TG/T | 5.06E-5 | 515 | 47.73 | 33.7 | 28.7 | KM Plot |
KIRC | rs66790453 | chr6:26107088 | C/T | 1.26E-8 | 510 | 41.27 | 36.95 | 3.37 | KM Plot |
KIRC | rs66834257 | chr6:50809141 | G/A | 4.63E-6 | 521 | 40.5 | 40.3 | 15.3 | KM Plot |
KIRC | rs669052 | chr11:125342130 | A/C | 4.84E-6 | 513 | 40.57 | 37.37 | 1.43 | KM Plot |
KIRC | rs66983783 | chr6:25821992 | TATACA/T | 4.72E-5 | 525 | 42.2 | 30.92 | 4.1 | KM Plot |
KIRC | rs67092917 | chr6:50815333 | G/T | 5.17E-6 | 519 | 40.5 | 40.3 | 15.3 | KM Plot |
KIRC | rs67296946 | chr6:26048559 | T/G | 6.04E-9 | 523 | 41.27 | 36.63 | 3.37 | KM Plot |
KIRC | rs67554133 | chr6:25866232 | T/A | 1.74E-5 | 521 | 41.13 | 33.93 | 4.1 | KM Plot |
KIRC | rs6760857 | chr2:67559647 | G/A | 4.41E-7 | 518 | 39.23 | 37.67 | 2.03 | KM Plot |
KIRC | rs6782166 | chr3:48351683 | A/G | 3.27E-5 | 523 | 39.62 | 41.27 | 19.13 | KM Plot |
KIRC | rs67844427 | chr6:25931020 | G/A | 2.11E-5 | 522 | 41.27 | 33.82 | 4.1 | KM Plot |
KIRC | rs679182 | chr11:125326058 | G/C | 3.87E-6 | 512 | 43 | 35.17 | 1.43 | KM Plot |